- Home
- APM vs TGL Comparison
APM vs TGL Comparison
Compare APM & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- TGL
- Stock Information
- Founded
- APM 2010
- TGL 2020
- Country
- APM United Kingdom
- TGL United States
- Employees
- APM N/A
- TGL N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- TGL Retail: Computer Software & Peripheral Equipment
- Sector
- APM Health Care
- TGL Technology
- Exchange
- APM Nasdaq
- TGL Nasdaq
- Market Cap
- APM 6.1M
- TGL N/A
- IPO Year
- APM 2018
- TGL 2022
- Fundamental
- Price
- APM $0.93
- TGL $1.93
- Analyst Decision
- APM
- TGL
- Analyst Count
- APM 0
- TGL 0
- Target Price
- APM N/A
- TGL N/A
- AVG Volume (30 Days)
- APM 137.3K
- TGL 6.3M
- Earning Date
- APM 05-20-2025
- TGL 05-20-2025
- Dividend Yield
- APM N/A
- TGL N/A
- EPS Growth
- APM N/A
- TGL N/A
- EPS
- APM N/A
- TGL N/A
- Revenue
- APM N/A
- TGL $2,398,398.00
- Revenue This Year
- APM N/A
- TGL N/A
- Revenue Next Year
- APM N/A
- TGL N/A
- P/E Ratio
- APM N/A
- TGL N/A
- Revenue Growth
- APM N/A
- TGL N/A
- 52 Week Low
- APM $0.46
- TGL $1.71
- 52 Week High
- APM $7.49
- TGL $300.00
- Technical
- Relative Strength Index (RSI)
- APM 52.79
- TGL 36.72
- Support Level
- APM $0.80
- TGL $1.62
- Resistance Level
- APM $0.96
- TGL $2.77
- Average True Range (ATR)
- APM 0.07
- TGL 0.19
- MACD
- APM -0.00
- TGL 0.09
- Stochastic Oscillator
- APM 68.36
- TGL 26.96
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.